New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2013
07:17 EDTPACB, ILMN, FLDM, LIFELeerink to host a tour
Genomics Lab Tour consists of a tour of the Kansas University Medical Center's Genomics Lab and discusses the demand for DNA sequencing technologies, interest in new products, impact of funding constraints and DNA sequencing in the clinic. Relevant covered companies include Illumina, Life Technologies, Fluidigm and Pacific Biosciences. The tour is in Kansas City, Kansas and starts at 2 pm on March 27.
News For ILMN;LIFE;FLDM;PACB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 23, 2015
15:46 EDTPACB, ILMN, FLDMPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
January 21, 2015
10:24 EDTILMNIllumina pulls back following State of the Union address
Shares of Illumina (ILMN) rose yesterday after a biotech industry website reported that President Obama might unveil a major new genomics project during his State of the Union address last night. That speculation was backed as a possibility by an analyst at Wells Fargo ahead of last night's address. In the speech, President Obama unveiled what he called his Precision Medicine Initiative, which relies on genomics to "deliver(s) the right treatment at the right time." Obama spent far more time, however, discussing economic growth and foreign relations than healthcare. Illumina shares are down 3% to $190.64 in early trading today.
January 20, 2015
13:45 EDTILMNIllumina rises as genomics project seen being announced in State of the Union
Subscribe for More Information
11:24 EDTILMNIllumina could see headline boost from U.S. genomics project, says Wells Fargo
After biotech industry publication BioCentury said Friday that the president may announce a new genomics project to sequence up to one million human genomes as part of his State of the Union speech tonight, Wells Fargo said that it believes such an announcement could be a headline catalyst for Illumina since it would mean the U.S. needs additional sequencing capacity. However, such a project would be long-term in nature, Wells Fargo cautioned, adding that such a plan would more likely support existing Illumina growth assumptions than push those forecasts up. Shares of Illumina are up 6% to $194.85 in morning trading ahead of tonight's speech by the president.
07:53 EDTFLDMFluidigm upgraded to Outperform at Cowen
Subscribe for More Information
06:36 EDTFLDMFluidigm upgraded to Outperform from Market Perform at Cowen
Subscribe for More Information
January 13, 2015
16:02 EDTFLDMFluidigm sees FY15 revenue $142M-$149M, consensus $149.02M
Subscribe for More Information
16:02 EDTFLDMFluidigm sees FY14 revenue approximately $116.4M, consensus $116.27M
Organic revenue for the full year of 2014 (excluding revenue attributable to the DVS Sciences acquisition, comprised of the CyTOF 2 system and proteomics analytical consumables) is expected to be approximately $95.9M.
16:01 EDTFLDMFluidigm sees Q4 revenue approximately $33.4M, consensus $33.33M
Subscribe for More Information
January 12, 2015
14:47 EDTILMNIllumina sees FY15 EPS $3.12-$3.18, consensus $3.17
Sees FY15 20% revenue growth of 20%, consensus $2.26B.
14:45 EDTILMNIllumina sees Q4 EPS 'slightly above' high end of prior view
Subscribe for More Information
14:42 EDTILMNIllumina options active on guidance
Subscribe for More Information
14:42 EDTILMNLockheed Martin, Illumina announce strategic alliance
Subscribe for More Information
14:09 EDTILMNIllumina sees FY15 revenue growth of 20%, consensus $2.26B
Guidance issued during presentation at JPMorgan Healthcare Conference.
14:08 EDTILMNIllumina sees Q4 revenue $512M, consensus $503.83M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use